Commentary: pediatric antifungal drug development: lessons learned and recommendations for the future

Pediatr Infect Dis J. 2012 Jun;31(6):635-7. doi: 10.1097/INF.0b013e31824f8426.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antifungal Agents / pharmacokinetics*
  • Candidemia / drug therapy*
  • Candidiasis, Invasive / drug therapy*
  • Echinocandins / pharmacokinetics*
  • Female
  • Humans
  • Lipopeptides / pharmacokinetics*
  • Male
  • Micafungin

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Micafungin